1. Home
  2. CNXU vs SEER Comparison

CNXU vs SEER Comparison

Compare CNXU & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$3.32

Market Cap

111.7M

Sector

Health Care

ML Signal

N/A

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$2.20

Market Cap

108.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNXU
SEER
Founded
2022
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.7M
108.0M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
CNXU
SEER
Price
$3.32
$2.20
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
163.1K
★ 211.8K
Earning Date
02-03-2027
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9.40
EPS
★ N/A
N/A
Revenue
N/A
★ $16,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.50
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.99
52 Week Low
$3.60
$1.55
52 Week High
$13.66
$2.41

Technical Indicators

Market Signals
Indicator
CNXU
SEER
Relative Strength Index (RSI) 29.51 66.80
Support Level N/A $1.81
Resistance Level $5.47 $2.24
Average True Range (ATR) 0.41 0.08
MACD 0.02 0.04
Stochastic Oscillator 2.97 81.63

Price Performance

Historical Comparison
CNXU
SEER

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: